Cargando…
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
Tamoxifen (tam) is used extensively for treatment of patients with breast cancer and is being evaluated for chemoprevention in healthy women. It has, however, been reported to increase the risk of endometrial cancer in post-menopausal women, probably by an oestrogenic effect on the endometrium. It a...
Autores principales: | Powles, T. J., Bourne, T., Athanasiou, S., Chang, J., Gruböck, K., Ashley, S., Oakes, L., Tidy, A., Davey, J., Viggers, J., Humphries, S., Collins, W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062882/ https://www.ncbi.nlm.nih.gov/pubmed/9683306 |
Ejemplares similares
-
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia
por: Girbash, Ehab F., et al.
Publicado: (2023) -
Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment
por: Ciatto, S, et al.
Publicado: (2003) -
Role of transvaginal ultrasonography in diagnosing endometrial hyperplasia in pre- and post-menopause women
por: Shokouhi, Behrooz
Publicado: (2015) -
Effects of 17β-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women
por: Wide, Leif, et al.
Publicado: (2010) -
Evaluation of endometrial thickness by transvaginal ultrasound and baseline risk factors as a predictor for endometrial abnormalities in postmenopausal women
por: Yerrisani, Jyothirmayi, et al.
Publicado: (2022)